MX2024005600A - Metodos y composiciones para tratar afecciones asociadas con hipoventilacion central. - Google Patents

Metodos y composiciones para tratar afecciones asociadas con hipoventilacion central.

Info

Publication number
MX2024005600A
MX2024005600A MX2024005600A MX2024005600A MX2024005600A MX 2024005600 A MX2024005600 A MX 2024005600A MX 2024005600 A MX2024005600 A MX 2024005600A MX 2024005600 A MX2024005600 A MX 2024005600A MX 2024005600 A MX2024005600 A MX 2024005600A
Authority
MX
Mexico
Prior art keywords
methods
conditions associated
treating conditions
compositions
central hypoventilation
Prior art date
Application number
MX2024005600A
Other languages
English (en)
Spanish (es)
Inventor
Lawrence G Miller
Ronald Farkas
Luigi Taranto-Montemurro
David P White
Original Assignee
Apnimed Inc Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apnimed Inc Delaware filed Critical Apnimed Inc Delaware
Publication of MX2024005600A publication Critical patent/MX2024005600A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2024005600A 2021-11-11 2022-11-10 Metodos y composiciones para tratar afecciones asociadas con hipoventilacion central. MX2024005600A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163278324P 2021-11-11 2021-11-11
US202263305305P 2022-02-01 2022-02-01
PCT/US2022/049483 WO2023086433A1 (en) 2021-11-11 2022-11-10 Methods and compositions for treating conditions associated with central hypoventilation

Publications (1)

Publication Number Publication Date
MX2024005600A true MX2024005600A (es) 2024-05-21

Family

ID=84627454

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024005600A MX2024005600A (es) 2021-11-11 2022-11-10 Metodos y composiciones para tratar afecciones asociadas con hipoventilacion central.

Country Status (9)

Country Link
US (1) US20250000823A1 (cg-RX-API-DMAC7.html)
EP (1) EP4429649A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024541315A (cg-RX-API-DMAC7.html)
KR (1) KR20240108453A (cg-RX-API-DMAC7.html)
AU (1) AU2022387440A1 (cg-RX-API-DMAC7.html)
CA (1) CA3237151A1 (cg-RX-API-DMAC7.html)
IL (1) IL312688A (cg-RX-API-DMAC7.html)
MX (1) MX2024005600A (cg-RX-API-DMAC7.html)
WO (1) WO2023086433A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025207125A1 (en) * 2024-03-26 2025-10-02 The Regents Of The University Of California Combination pharmacological interventions for obstructive sleep apnea

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
EP3685858A1 (en) * 2019-01-24 2020-07-29 Assistance Publique-Hopitaux De Paris A noradrenergic system stimulator in the treatment of central hypoventilation syndromes
US20220362221A1 (en) * 2019-11-04 2022-11-17 Apnimed, Inc. (Delaware) Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea

Also Published As

Publication number Publication date
US20250000823A1 (en) 2025-01-02
EP4429649A1 (en) 2024-09-18
WO2023086433A1 (en) 2023-05-19
KR20240108453A (ko) 2024-07-09
JP2024541315A (ja) 2024-11-08
CA3237151A1 (en) 2023-05-19
AU2022387440A1 (en) 2024-05-23
IL312688A (en) 2024-07-01

Similar Documents

Publication Publication Date Title
CL2023000622S1 (es) Banda para dispositivo
CL2021000384S1 (es) Banda tipo pulsera para un dispositivo.
CL2023000619S1 (es) Banda para dispositivo
CL2023000608S1 (es) Banda para dispositivo
CL2023000613S1 (es) Banda para dispositivo
CO2021008776A2 (es) Inhibidores de il-17a
DOP2025000200A (es) Compuestos y métodos para modular ras-pi3k
CL2023000223A1 (es) Nuevos inhibidores selectivos de hdac6 basados en oxadiazol
BR112021020285A2 (pt) Métodos e composições para degradação de proteína alvejada
CL2021000385S1 (es) Banda tipo pulsera para un dispositivo.
BR112022021381A2 (pt) Compostos para o tratamento de sars
ECSP099525A (es) Inhibidores de mek
CL2021001461A1 (es) Moduladores de trex1
BR112013018779A2 (pt) composto, composição farmacêutica, e, método para tratar uma condição ou um distúrbio
CL2024000731S1 (es) Banda para dispositivo.
CL2023000611S1 (es) Banda para dispositivo
MX2021010869A (es) Bloqueadores de canales iónicos sustituidos por éster y métodos para su uso.
CL2023000615S1 (es) Banda para dispositivo
MX2021000469A (es) Inhibidores biciclicos de las histona desacetilasas.
BR112022023187A2 (pt) Compostos para o tratamento da sars
CO2025001287A2 (es) Inhibidores de la proteasa principal de sars-cov2
EP4486741A4 (en) Diacylglycerol Kinase (DGK) Alpha Inhibitors and Their Uses
JOP20220290A1 (ar) مثبطات إنزيم الجلوكوسيل سيراميداز غير المتعلقة بالجسيم الحال واستخدامتها
EA202190077A1 (ru) Ингибиторы гистондеацетилазы
GEP20257794B (en) Magl inhibitor